HoldingsChannel.com
| Entity | Amount | Change
09/30/2023 to 12/31/2023 |
Position Size ($ in 1000's) |
|---|---|---|---|
 APELLIS PHARMACEUTICALS INC |
2,806,980 | -48,020 | $168,026 |
| APLS | 2,806,980 | -323,020 | $168,026 |
| CYMABAY THERAPEUTICS INC |
2,673,750 | -340,000 | $63,154 |
| CBAY | 2,673,750 | -400,000 | $63,154 |
| VERONA PHARMA PLC |
2,369,000 | UNCH | $47,096 |
| VRNA | 2,369,000 | UNCH | $47,096 |
| INSMED INC |
1,284,000 | UNCH | $39,791 |
| INSM | 1,284,000 | UNCH | $39,791 |
| ARCUS BIOSCIENCES INC |
1,868,000 | -100,000 | $35,679 |
| RCUS | 1,868,000 | -100,000 | $35,679 |
| BRIDGEBIO PHARMA INC |
706,800 | -264,839 | $28,534 |
| BBIO | 706,800 | -264,839 | $28,534 |
| CELLDEX THERAPEUTICS INC NEW |
707,526 | -52,372 | $28,060 |
| CLDX | 707,526 | -52,372 | $28,060 |
| ROIVANT SCIENCES LTD |
2,494,000 | -1,873,000 | $28,008 |
| ROIV | 2,494,000 | -1,873,000 | $28,008 |
| ALPINE IMMUNE SCIENCES INC |
1,241,300 | +491,300 | $23,659 |
| ALPN | 1,241,300 | +491,300 | $23,659 |
| STRUCTURE THERAPEUTICS INC |
414,000 | +414,000 | $16,875 |
| GPCR | 414,000 | +414,000 | $16,875 |
| CENTESSA PHARMACEUTICALS PLC |
2,060,100 | +1,584,500 | $16,398 |
| CNTA | 2,060,100 | +1,584,500 | $16,398 |
| AN2 THERAPEUTICS INC |
664,575 | -203,000 | $13,617 |
| ANTX | 664,575 | -203,000 | $13,617 |
| VIRIDIAN THERAPEUTICS INC |
620,000 | -447,143 | $13,504 |
| VRDN | 620,000 | -447,143 | $13,504 |
| IMMUNOVANT INC |
273,289 | +1,273,289 | $11,514 |
| IMVT | 273,289 | +273,289 | $11,514 |
| DYNE THERAPEUTICS INC |
792,945 | +100,000 | $10,546 |
| DYN | 792,945 | +100,000 | $10,546 |
| CYTOKINETICS INC |
116,000 | +116,000 | $9,685 |
| CYTK | 116,000 | +116,000 | $9,685 |
| ANNEXON INC |
2,050,000 | UNCH | $9,307 |
| ANNX | 2,050,000 | UNCH | $9,307 |
| AEROVATE THERAPEUTICS INC |
403,685 | -93,685 | $9,135 |
| AVTE | 403,685 | -93,685 | $9,135 |
| GOSSAMER BIO INC |
9,187,883 | +1,000,000 | $8,384 |
| GOSS | 9,187,883 | +1,000,000 | $8,384 |
| RAPT THERAPEUTICS INC |
292,000 | +292,000 | $7,256 |
| RAPT | 292,000 | +292,000 | $7,256 |
| GLYCOMIMETICS INC |
3,000,000 | UNCH | $7,080 |
| GLYC | 3,000,000 | UNCH | $7,080 |
| GRACELL BIOTECHNOLOGIES INC |
596,611 | +596,611 | $5,990 |
| GRCL | 596,611 | +596,611 | $5,990 |
| DIANTHUS THERAPEUTICS INC |
554,000 | +74,000 | $5,762 |
| DNTH | 554,000 | +74,000 | $5,762 |
| RENEO PHARMACEUTICALS INC |
2,250,000 | -29,870 | $3,600 |
| RPHM | 2,250,000 | -29,870 | $3,600 |
| JASPER THERAPEUTICS INC |
4,468,114 | UNCH | $3,525 |
| JSPR | 4,468,114 | UNCH | $3,525 |
| VERU INC |
3,800,000 | +3,800,000 | $2,736 |
| VERU | 3,800,000 | +3,800,000 | $2,736 |
| ANAPTYSBIO INC |
120,000 | +120,000 | $2,570 |
| ANAB | 120,000 | +120,000 | $2,570 |
| INOZYME PHARMA INC |
400,000 | -900,000 | $1,704 |
| INZY | 400,000 | -900,000 | $1,704 |
| NUVATION BIO INC |
1,000,000 | +1,000,000 | $1,510 |
| NUVB | 1,000,000 | +1,000,000 | $1,510 |
| XILIO THERAPEUTICS INC |
1,785,000 | -533,500 | $982 |
| XLO | 1,785,000 | -533,500 | $982 |
| MIRUM PHARMACEUTICALS INC |
25,000 | +25,000 | $738 |
| MIRM | 25,000 | +25,000 | $738 |
| PHATHOM PHARMACEUTICALS INC |
50,000 | +50,000 | $456 |
| PHAT | 50,000 | +50,000 | $456 |
| ACLARIS THERAPEUTICS INC |
100,000 | +100,000 | $105 |
| ACRS | 100,000 | +100,000 | $105 |
 AMYLYX PHARMACEUTICALS INC |
$0 (exited) | ||
| AMLX | 0 | -695,000 | $0 |
| BIONOMICS LIMITED |
$0 (exited) | ||
| BNOX | 0 | -168,000 | $0 |
| 89BIO INC |
$0 (exited) | ||
| ETNB | 0 | -1,219,157 | $0 |
| MONTE ROSA THERAPEUTICS INC |
$0 (exited) | ||
| GLUE | 0 | -812,895 | $0 |
| HEPION PHARMACEUTICALS INC |
$0 (exited) | ||
| HEPA | 0 | -67,500 | $0 |
| ITEOS THERAPEUTICS INC |
$0 (exited) | ||
| ITOS | 0 | -102,000 | $0 |
| LEXICON PHARMACEUTICALS INC |
$0 (exited) | ||
| LXRX | 0 | -1,923,076 | $0 |
| MIRATI THERAPEUTICS INC |
$0 (exited) | ||
| MRTX | 0 | -655,051 | $0 |
| ORIC PHARMACEUTICALS INC |
$0 (exited) | ||
| ORIC | 0 | -204,500 | $0 |
| PMV PHARMACEUTICALS INC |
$0 (exited) | ||
| PMVP | 0 | -904,000 | $0 |
| TAYSHA GENE THERAPIES INC |
$0 (exited) | ||
| TSHA | 0 | -2,777,778 | $0 |
| TRAVERE THERAPEUTICS INC |
$0 (exited) | ||
| Call | 0 | -300,000 | $0 |
| VIR BIOTECHNOLOGY INC |
$0 (exited) | ||
| VIR | 0 | -325,050 | $0 |
| VIKING THERAPEUTICS INC |
0 | -375,000 | $0 (exited) |
| VKTX | 0 | -375,000 | $0 |
See Summary: Octagon Capital Advisors LP Top Holdings
See Details: Top 10 Stocks Held By Octagon Capital Advisors LP
| Entity | Shares/Amount Change | Position Value Change |
|---|---|---|
| GPCR | +414,000 | +$16,875 |
| CYTK | +116,000 | +$9,685 |
| RAPT | +292,000 | +$7,256 |
| GRCL | +596,611 | +$5,990 |
| VERU | +3,800,000 | +$2,736 |
| ANAB | +120,000 | +$2,570 |
| NUVB | +1,000,000 | +$1,510 |
| MIRM | +25,000 | +$738 |
| PHAT | +50,000 | +$456 |
| ACRS | +100,000 | +$105 |
| Entity | Shares/Amount Change | Position Value Change |
|---|---|---|
| MRTX | -655,051 | -$28,534 |
| ETNB | -1,219,157 | -$18,824 |
| AMLX | -695,000 | -$12,725 |
| TSHA | -2,777,778 | -$8,778 |
| PMVP | -904,000 | -$5,551 |
| VKTX | -375,000 | -$4,151 |
| GLUE | -812,895 | -$3,894 |
| VIR | -325,050 | -$3,046 |
| TVTX | -300,000 | -$2,682 |
| LXRX | -1,923,076 | -$2,096 |
| Entity | Shares/Amount Change | Position Value Change |
|---|---|---|
| CNTA | +1,584,500 | +$13,321 |
| IMVT | +1,273,289 | +$49,904 |
| GOSS | +1,000,000 | +$1,565 |
| ALPN | +491,300 | +$15,071 |
| DYN | +100,000 | +$4,337 |
| DNTH | +74,000 | -$800 |
| VRNA | UNCH | +$8,481 |
| INSM | UNCH | +$7,370 |
| ANNX | UNCH | +$4,469 |
| GLYC | UNCH | +$2,580 |
| Entity | Shares/Amount Change | Position Value Change |
|---|---|---|
| ROIV | -1,873,000 | -$22,999 |
| INZY | -900,000 | -$3,756 |
| XLO | -533,500 | -$3,910 |
| VRDN | -447,143 | -$2,866 |
| CBAY | -340,000 | +$18,219 |
| BBIO | -264,839 | +$2,912 |
| ANTX | -203,000 | -$334 |
| RCUS | -100,000 | +$353 |
| AVTE | -93,685 | +$2,386 |
|
Size ($ in 1000's)
At 12/31/2023: $624,986 At 09/30/2023: $650,906 Octagon Capital Advisors LP holdings changes, total fund size, and other information presented on HoldingsChannel.com was derived from Octagon Capital Advisors LP 13F filings. Link to 13F filings: SEC filings |
